Custom immune cells take on advanced colorectal cancer in new trial
Disease control
Recruiting now
This early-stage trial is testing a personalized T-cell therapy called iNeo-Vac-T01 for people with advanced colorectal cancer that has spread. The treatment is made from each patient's own immune cells, which are trained to recognize unique markers on their tumor. The study will…
Phase: PHASE1 • Sponsor: Ying Yuan, MD • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC